Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia

Acute myeloid leukemia (AML) is a malignant disorder derived from neoplastic myeloid progenitor cells characterized by abnormal proliferation and differentiation. Although novel therapeutics have recently been introduced, AML remains a therapeutic challenge with insufficient cure rates. In the last...

Descripción completa

Detalles Bibliográficos
Autores principales: Albinger, Nawid, Pfeifer, Rita, Nitsche, Marcus, Mertlitz, Sarah, Campe, Julia, Stein, Katja, Kreyenberg, Hermann, Schubert, Ralf, Quadflieg, Melissa, Schneider, Dina, Kühn, Michael W. M., Penack, Olaf, Zhang, Congcong, Möker, Nina, Ullrich, Evelyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007937/
https://www.ncbi.nlm.nih.gov/pubmed/35418180
http://dx.doi.org/10.1038/s41408-022-00660-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007937/
https://www.ncbi.nlm.nih.gov/pubmed/35418180
http://dx.doi.org/10.1038/s41408-022-00660-2

Ejemplares similares